| mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
JQ12 |
GDSC1000 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
| mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.9 |
| mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
| mRNA |
Dasatinib |
FIMM |
pan-cancer |
AAC |
0.022 |
0.9 |
| mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |